Insider Selling: Omnicell CFO Sells 27,500 Shares of Stock (OMCL)
Omnicell (NASDAQ:OMCL) CFO Robin Gene Seim unloaded 27,500 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $24.35, for a total transaction of $669,625.00. Following the transaction, the chief financial officer now directly owns 69,700 shares of the company’s stock, valued at approximately $1,697,195. The sale was disclosed in a legal filing with the SEC, which is available at this link.
OMCL has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Omnicell (NASDAQ:OMCL) in a research note to investors on Wednesday, August 21st. They now have a $24.00 price target on the stock. Analysts at Cowen and Company raised their price target on shares of Omnicell (NASDAQ:OMCL) from $18.00 to $21.00 in a research note to investors on Friday, August 2nd. They now have a “market perform” rating on the stock.
Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Omnicell currently has an average rating of “Hold” and an average price target of $22.00.
Omnicell (NASDAQ:OMCL) traded up 0.52% during mid-day trading on Tuesday, hitting $24.98. 286,712 shares of the company’s stock traded hands. Omnicell has a 52-week low of $12.61 and a 52-week high of $25.09. The stock’s 50-day moving average is $23.23 and its 200-day moving average is $20.09. The company has a market cap of $870.3 million and a price-to-earnings ratio of 39.44.
Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, August 1st. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.25 by $0.02. The company had revenue of $93.70 million for the quarter, compared to the consensus estimate of $92.42 million. During the same quarter last year, the company posted $0.20 earnings per share. Omnicell’s revenue was up 24.3% compared to the same quarter last year. On average, analysts predict that Omnicell will post $1.05 earnings per share for the current fiscal year.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.